BioVaxys Technology (TSE:BIOV) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioVaxys Technology Corp. has successfully closed the second tranche of its non-brokered private placement, raising $175,000 by issuing 3.5 million units at $0.05 per unit. The funds will be used to boost the company’s working capital, with each unit comprising one common share and a warrant convertible at $0.15 by December 2026.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.